Nalaganje...

Targeting Human Immunodeficiency Virus Type 1 Assembly, Maturation and Budding

The targets for licensed drugs used for the treatment of human immunodeficiency virus type 1 (HIV-1) are confined to the viral reverse transcriptase (RT), protease (PR), and the gp41 transmembrane protein (TM). While currently approved drugs are effective in controlling HIV-1 infections, new drug ta...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Wapling, Johanna, Srivastava, Seema, Shehu-Xhilaga, Miranda, Tachedjian, Gilda
Format: Artigo
Jezik:Inglês
Izdano: Libertas Academica 2007
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3155237/
https://ncbi.nlm.nih.gov/pubmed/21901072
Oznake: Označite
Brez oznak, prvi označite!